{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:04:12Z","timestamp":1784948652453,"version":"3.55.0"},"reference-count":48,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2020,5,23]]},"DOI":"10.1080\/14656566.2020.1729123","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T14:29:05Z","timestamp":1582900145000},"page":"871-882","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":22,"title":["Clinical pharmacology of imeglimin for the treatment of type 2 diabetes"],"prefix":"10.1080","volume":"21","author":[{"given":"Karl Sebastian","family":"Johansson","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Br\u00f8nden","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark"},{"name":"Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip Krag","family":"Knop","sequence":"additional","affiliation":[{"name":"Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"},{"name":"Steno Diabetes Center, Gentofte, Denmark"},{"name":"Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel Bring","family":"Christensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark"},{"name":"Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,2,28]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.02.023"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.2337\/db16-0806"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62154-6"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.11.012"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38678.389583.7C"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60768-0"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-S006"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-S008"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0413"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.2007.S368"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1210\/er.2014-1035"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.2337\/ds16-0026"},{"key":"cit0013","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MED.0000000000000311","volume":"24","author":"Hsia DS","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.249"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.1.154"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166125"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1465"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1630"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-017-0853-8"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2013.752813"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1727"},{"key":"cit0022","unstructured":"Poxel. Imeglimin - US\/EU [Internet]. [cited 2019 Jun 14]. Available from: https:\/\/www.poxelpharma.com\/en_us\/product-pipeline\/imeglimin-us-eu."},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01611.x"},{"key":"cit0024","volume-title":"Clinical evidence to support the safety and efficacy of imeglimin in various populations of patients with type 2 diabetes [Internet]","author":"Dubourg J","year":"2019"},{"key":"cit0025","first-page":"02","author":"Fouqueray P","year":"2011","journal-title":"J Diabetes Metab"},{"key":"cit0026","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1007\/s00125-015-3801-7","volume":"59","author":"Fouqueray F","year":"2016","journal-title":"DIABETOLOG"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.2337\/db16-861-1374"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.2337\/db16-861-1374"},{"key":"cit0029","author":"Hallakou-Bozec S","year":"2017","journal-title":"Endocr Pract"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy565.P2500"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12937"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.2337\/db18-81-OR"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1220"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00009.2016"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1038\/cddiscovery.2015.72"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0453"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2349"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12452"},{"key":"cit0039","first-page":"A301","volume":"64","author":"Fouqueray, Fouqueray","year":"2015","journal-title":"DIABETES"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4350-z"},{"key":"cit0041","unstructured":"Poxel SA Poxel and sumitomo dainippon pharma announce positive top-line results for imeglimin phase 3 trial (TIMES 1) in Japan for the treatment of type 2 diabetes [Internet]. [cited 2019 Jun 25]. Available from: https:\/\/www.poxelpharma.com\/en_us\/news-media\/press-releases\/detail\/117\/poxel-and-sumitomo-dainippon-pharma-announce-positive."},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.8b02507"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4342-z"},{"key":"cit0044","unstructured":"Poxel. Imeglimin - Japan\/Asia [Internet]. 2019 [cited 2019 Jul 9]. Available from: https:\/\/www.poxelpharma.com\/en_us\/product-pipeline\/imeglimin-japan."},{"key":"cit0045","unstructured":"JAPIC Clinical Trials Information [Internet]. 2019 [cited 2019 Jul 9]. Available from: https:\/\/www.clinicaltrials.jp\/."},{"key":"cit0046","unstructured":"PMDA. Guideline for clinical evaluation of oral hypoglycemic agents [Internet]. 2010 [cited 2019 Jul 9]. Available from: http:\/\/www.pmda.go.jp\/files\/000153859.pdf."},{"key":"cit0047","unstructured":"FDA. Guidance for industry diabetes mellitus \u2014 evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes [Internet]. 2008 [cited 2019 Jun 28]. Available from: https:\/\/www.fda.gov\/media\/71297\/download."},{"key":"cit0048","unstructured":"Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus [Internet]. 2012 [cited 2019 Jul 9]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-clinical-investigation-medicinal-products-treatment-prevention-diabetes-mellitus_en.pdf."}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2020.1729123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T20:58:23Z","timestamp":1695848303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2020.1729123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,28]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,5,23]]}},"alternative-id":["10.1080\/14656566.2020.1729123"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2020.1729123","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-10-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}